Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Inventory Average (2016 - 2018)

Historic Inventory Average for Theravance Biopharma (TBPH) over the last 5 years, with Q3 2018 value amounting to $17.9 million.

  • Theravance Biopharma's Inventory Average rose 3083.92% to $17.9 million in Q3 2018 from the same period last year, while for Sep 2018 it was $17.9 million, marking a year-over-year increase of 3083.92%. This contributed to the annual value of $14.5 million for FY2017, which is 3070.87% up from last year.
  • As of Q3 2018, Theravance Biopharma's Inventory Average stood at $17.9 million, which was up 3083.92% from $17.6 million recorded in Q2 2018.
  • Over the past 5 years, Theravance Biopharma's Inventory Average peaked at $17.9 million during Q3 2018, and registered a low of $9.6 million during Q2 2016.
  • Over the past 5 years, Theravance Biopharma's median Inventory Average value was $12.7 million (recorded in 2017), while the average stood at $13.2 million.
  • As far as peak fluctuations go, Theravance Biopharma's Inventory Average tumbled by 2279.63% in 2016, and later surged by 3860.15% in 2018.
  • Quarter analysis of 5 years shows Theravance Biopharma's Inventory Average stood at $13.8 million in 2014, then fell by 19.98% to $11.1 million in 2015, then increased by 11.53% to $12.4 million in 2016, then increased by 29.91% to $16.0 million in 2017, then rose by 11.66% to $17.9 million in 2018.
  • Its last three reported values are $17.9 million in Q3 2018, $17.6 million for Q2 2018, and $17.0 million during Q1 2018.